Kymera Therapeutics (KYMR)'s 30-day implied volatility (IV30) was 117.6% at the close on October 28, 2026, up from 114.2% the day before, against a 52-week range of 40.1% to 147.4%. Its 20-day historical volatility was 52.9%.
Data as of October 28, 2026.